JOHN C MARTIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN C MARTIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN C MARTIN. JOHN C MARTIN is Chairman and CEO in GILEAD SCIENCES INC ($GILD).
Latest Insider Trading Transactions of JOHN C MARTIN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 145,450 | 1,300,687 | 716,120 | |
Jul 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 51.32 | 145,450 | 7,464,683 | 1,989,938 | 2.1 M to 2 M (-6.81 %) |
Jul 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 145,450 | 1,300,687 | 2,135,388 | 2 M to 2.1 M (+7.31 %) |
Jul 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 29.02 | 733 | 21,271 | 1,989,938 | 2 M to 2 M (+0.04 %) |
Jun 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 145,450 | 1,300,687 | 861,570 | |
Jun 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 49.04 | 38,850 | 1,905,192 | 1,989,205 | 2 M to 2 M (-1.92 %) |
Jun 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 48.65 | 106,600 | 5,186,218 | 2,028,055 | 2.1 M to 2 M (-4.99 %) |
Jun 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 145,450 | 1,300,687 | 2,134,655 | 2 M to 2.1 M (+7.31 %) |
May 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 145,450 | 1,300,687 | 1,007,020 | |
May 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 51.71 | 145,450 | 7,521,496 | 1,989,205 | 2.1 M to 2 M (-6.81 %) |
May 03 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 145,450 | 1,300,687 | 2,134,655 | 2 M to 2.1 M (+7.31 %) |
Apr 04 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 145,450 | 1,300,687 | 1,152,470 | |
Apr 04 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 48.38 | 145,450 | 7,036,842 | 1,989,205 | 2.1 M to 2 M (-6.81 %) |
Apr 04 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 145,450 | 1,300,687 | 2,134,655 | 2 M to 2.1 M (+7.31 %) |
Mar 14 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Payment of Exercise | F | 46.16 | 35,010 | 1,616,062 | 1,989,205 | 2 M to 2 M (-1.73 %) |
Mar 14 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 75,000 | 0 | 2,024,215 | 1.9 M to 2 M (+3.85 %) |
Mar 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 145,450 | 1,300,687 | 1,297,920 | |
Mar 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 46.23 | 145,450 | 6,723,804 | 1,949,215 | 2.1 M to 1.9 M (-6.94 %) |
Mar 05 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 145,450 | 1,300,687 | 2,094,665 | 1.9 M to 2.1 M (+7.46 %) |
Feb 09 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.94 | 145,450 | 1,300,687 | 0 | |
Feb 09 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 55.20 | 90,150 | 4,976,641 | 1,949,215 | 2 M to 1.9 M (-4.42 %) |
Feb 09 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 54.92 | 55,300 | 3,036,888 | 2,039,365 | 2.1 M to 2 M (-2.64 %) |
Feb 09 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.94 | 145,450 | 1,300,687 | 2,094,665 | 1.9 M to 2.1 M (+7.46 %) |
Jan 30 2012 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | A | 48.59 | 331,000 | 16,083,290 | 331,000 | |
Dec 07 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 46,300 | 380,530 | 0 | |
Dec 07 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 40.00 | 46,300 | 1,852,000 | 1,949,215 | 2 M to 1.9 M (-2.32 %) |
Dec 07 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 46,300 | 380,530 | 1,995,515 | 1.9 M to 2 M (+2.38 %) |
Dec 05 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 1,300 | 10,684 | 46,300 | |
Dec 05 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 44,720 | 367,545 | 47,600 | |
Dec 05 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 40.00 | 1,300 | 52,000 | 1,949,215 | 2 M to 1.9 M (-0.07 %) |
Dec 05 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 1,300 | 10,684 | 1,950,515 | 1.9 M to 2 M (+0.07 %) |
Dec 05 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 40.01 | 44,720 | 1,789,068 | 1,949,215 | 2 M to 1.9 M (-2.24 %) |
Dec 05 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 44,720 | 367,545 | 1,993,935 | 1.9 M to 2 M (+2.29 %) |
Nov 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 92,320 | 758,760 | 92,320 | |
Nov 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 41.05 | 92,320 | 3,789,745 | 1,949,215 | 2 M to 1.9 M (-4.52 %) |
Nov 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 92,320 | 758,760 | 2,041,535 | 1.9 M to 2 M (+4.74 %) |
Oct 12 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 92,320 | 758,760 | 184,640 | |
Oct 12 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 40.00 | 92,320 | 3,693,169 | 1,949,215 | 2 M to 1.9 M (-4.52 %) |
Oct 12 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 92,320 | 758,760 | 2,041,535 | 1.9 M to 2 M (+4.74 %) |
Sep 06 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 92,320 | 758,760 | 276,960 | |
Sep 06 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 40.07 | 92,320 | 3,699,013 | 1,949,215 | 2 M to 1.9 M (-4.52 %) |
Sep 06 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 92,320 | 758,760 | 2,041,535 | 1.9 M to 2 M (+4.74 %) |
Aug 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 92,320 | 758,760 | 369,280 | |
Aug 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 42.44 | 16,920 | 718,073 | 1,949,215 | 2 M to 1.9 M (-0.86 %) |
Aug 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 41.55 | 75,400 | 3,133,172 | 1,966,135 | 2 M to 2 M (-3.69 %) |
Aug 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 92,320 | 758,760 | 2,041,535 | 1.9 M to 2 M (+4.74 %) |
Jul 06 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 92,320 | 758,760 | 553,920 | |
Jul 06 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 41.76 | 92,320 | 3,855,634 | 1,949,215 | 2 M to 1.9 M (-4.52 %) |
Jul 06 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 92,320 | 758,760 | 2,041,535 | 1.9 M to 2 M (+4.74 %) |
Jun 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 92,320 | 758,760 | 553,920 | |
Jun 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 41.50 | 92,320 | 3,830,966 | 1,948,483 | 2 M to 1.9 M (-4.52 %) |
Jun 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 92,320 | 758,760 | 2,040,803 | 1.9 M to 2 M (+4.74 %) |
May 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 92,320 | 758,760 | 646,240 | |
May 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 40.04 | 92,320 | 3,696,622 | 1,948,483 | 2 M to 1.9 M (-4.52 %) |
May 03 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 92,320 | 758,760 | 2,040,803 | 1.9 M to 2 M (+4.74 %) |
Apr 05 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 93,230 | 766,239 | 738,560 | |
Apr 05 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 42.50 | 92,320 | 3,923,157 | 1,948,483 | 2 M to 1.9 M (-4.52 %) |
Apr 05 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 92,320 | 758,760 | 2,040,803 | 1.9 M to 2 M (+4.74 %) |
Mar 17 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Payment of Exercise | F | 39.79 | 31,833 | 1,266,635 | 1,942,530 | 2 M to 1.9 M (-1.61 %) |
Mar 17 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 61,600 | 0 | 1,974,363 | 1.9 M to 2 M (+3.22 %) |
Mar 07 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 102,733 | 844,342 | 830,880 | |
Mar 07 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 174,227 | 1,431,937 | 933,613 | |
Mar 07 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 40.20 | 102,733 | 4,130,339 | 1,912,763 | 2 M to 1.9 M (-5.10 %) |
Mar 07 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 40.01 | 174,227 | 6,970,143 | 2,015,496 | 2.2 M to 2 M (-7.96 %) |
Mar 07 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 102,733 | 844,342 | 2,189,723 | 2.1 M to 2.2 M (+4.92 %) |
Mar 07 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 174,227 | 1,431,937 | 2,086,990 | 1.9 M to 2.1 M (+9.11 %) |
Jan 24 2011 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | A | 38.17 | 430,000 | 16,413,100 | 430,000 | |
Oct 26 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 140,984 | 521,542 | 0 | |
Oct 26 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 140,984 | 521,542 | 1,912,763 | 1.8 M to 1.9 M (+7.96 %) |
Aug 23 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 125,000 | 462,413 | 140,984 | |
Aug 23 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 125,000 | 462,413 | 1,771,779 | 1.6 M to 1.8 M (+7.59 %) |
Aug 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.22 | 12,160 | 99,941 | 0 | |
Aug 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.22 | 12,160 | 99,941 | 1,646,779 | 1.6 M to 1.6 M (+0.74 %) |
Jul 15 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 369,930 | 265,984 | |
Jul 15 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 35.15 | 100,000 | 3,515,000 | 1,634,042 | 1.7 M to 1.6 M (-5.77 %) |
Jul 15 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 369,930 | 1,734,042 | 1.6 M to 1.7 M (+6.12 %) |
Jun 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 369,930 | 365,984 | |
Jun 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 34.24 | 36,700 | 1,256,678 | 1,634,042 | 1.7 M to 1.6 M (-2.20 %) |
Jun 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 33.41 | 63,300 | 2,114,764 | 1,670,742 | 1.7 M to 1.7 M (-3.65 %) |
Jun 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 369,930 | 1,734,042 | 1.6 M to 1.7 M (+6.12 %) |
May 13 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 369,930 | 465,984 | |
May 13 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 40.00 | 19,100 | 764,021 | 1,634,042 | 1.7 M to 1.6 M (-1.16 %) |
May 13 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 39.52 | 80,900 | 3,196,909 | 1,653,142 | 1.7 M to 1.7 M (-4.67 %) |
May 13 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 369,930 | 1,734,042 | 1.6 M to 1.7 M (+6.12 %) |
Apr 15 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 369,930 | 565,984 | |
Apr 15 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 46.32 | 100,000 | 4,631,930 | 1,634,042 | 1.7 M to 1.6 M (-5.77 %) |
Apr 15 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 369,930 | 1,734,042 | 1.6 M to 1.7 M (+6.12 %) |
Mar 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 369,930 | 665,984 | |
Mar 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 47.44 | 100,000 | 4,743,710 | 1,634,042 | 1.7 M to 1.6 M (-5.77 %) |
Mar 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 369,930 | 1,734,042 | 1.6 M to 1.7 M (+6.12 %) |
Mar 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Payment of Exercise | F | 47.01 | 32,676 | 1,536,099 | 1,634,042 | 1.7 M to 1.6 M (-1.96 %) |
Mar 10 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 70,000 | 0 | 1,666,718 | 1.6 M to 1.7 M (+4.38 %) |
Feb 11 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 369,930 | 765,984 | |
Feb 11 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 46.37 | 100,000 | 4,637,340 | 1,596,718 | 1.7 M to 1.6 M (-5.89 %) |
Feb 11 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 369,930 | 1,696,718 | 1.6 M to 1.7 M (+6.26 %) |
Feb 01 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | A | 47.51 | 318,000 | 15,108,180 | 318,000 | |
Jan 14 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 66,992 | 247,824 | 865,984 | |
Jan 14 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 33,008 | 122,235 | 0 | |
Jan 14 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 44.80 | 100,000 | 4,479,970 | 1,596,718 | 1.7 M to 1.6 M (-5.89 %) |
Jan 14 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 66,992 | 247,824 | 1,696,718 | 1.6 M to 1.7 M (+4.11 %) |
Jan 14 2010 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 33,008 | 122,235 | 1,629,726 | 1.6 M to 1.6 M (+2.07 %) |
Dec 10 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 370,320 | 33,008 | |
Dec 10 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 46.16 | 100,000 | 4,616,300 | 1,596,718 | 1.7 M to 1.6 M (-5.89 %) |
Dec 10 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 370,320 | 1,696,718 | 1.6 M to 1.7 M (+6.26 %) |
Nov 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 370,320 | 133,008 | |
Nov 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 47.12 | 2,500 | 117,791 | 1,596,718 | 1.6 M to 1.6 M (-0.16 %) |
Nov 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 46.65 | 97,500 | 4,548,824 | 1,599,218 | 1.7 M to 1.6 M (-5.75 %) |
Nov 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 370,320 | 1,696,718 | 1.6 M to 1.7 M (+6.26 %) |
Oct 14 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 370,320 | 233,008 | |
Oct 14 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 45.40 | 100,000 | 4,540,070 | 1,596,718 | 1.7 M to 1.6 M (-5.89 %) |
Oct 14 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 370,320 | 1,696,718 | 1.6 M to 1.7 M (+6.26 %) |
Sep 09 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 370,320 | 333,008 | |
Sep 09 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 46.68 | 100,000 | 4,667,870 | 1,596,718 | 1.7 M to 1.6 M (-5.89 %) |
Sep 09 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 370,320 | 1,696,718 | 1.6 M to 1.7 M (+6.26 %) |
Aug 13 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 100,000 | 370,320 | 433,008 | |
Aug 13 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 45.44 | 100,000 | 4,543,710 | 1,596,718 | 1.7 M to 1.6 M (-5.89 %) |
Aug 13 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 100,000 | 370,320 | 1,696,718 | 1.6 M to 1.7 M (+6.26 %) |
Jul 16 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.65 | 100,000 | 364,850 | 0 | |
Jul 16 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 45.01 | 100,000 | 4,501,290 | 1,596,718 | 1.7 M to 1.6 M (-5.89 %) |
Jul 16 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.65 | 100,000 | 364,850 | 1,696,718 | 1.6 M to 1.7 M (+6.26 %) |
Jun 10 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.65 | 100,000 | 364,850 | 100,000 | |
Jun 10 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 44.36 | 100,000 | 4,436,470 | 1,596,239 | 1.7 M to 1.6 M (-5.90 %) |
Jun 10 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.65 | 100,000 | 364,850 | 1,696,239 | 1.6 M to 1.7 M (+6.26 %) |
May 14 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.65 | 100,000 | 364,850 | 200,000 | |
May 14 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 44.63 | 100,000 | 4,463,320 | 1,596,239 | 1.7 M to 1.6 M (-5.90 %) |
May 14 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.65 | 100,000 | 364,850 | 1,696,239 | 1.6 M to 1.7 M (+6.26 %) |
Apr 28 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.65 | 103,376 | 377,167 | 300,000 | |
Apr 28 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 45.92 | 103,376 | 4,747,026 | 1,596,239 | 1.7 M to 1.6 M (-6.08 %) |
Apr 28 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.65 | 103,376 | 377,167 | 1,699,615 | 1.6 M to 1.7 M (+6.48 %) |
Apr 15 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.65 | 100,000 | 364,850 | 403,376 | |
Apr 15 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 46.28 | 100,000 | 4,628,070 | 1,596,239 | 1.7 M to 1.6 M (-5.90 %) |
Apr 15 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.65 | 100,000 | 364,850 | 1,696,239 | 1.6 M to 1.7 M (+6.26 %) |
Mar 16 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Payment of Exercise | F | 44.04 | 16,014 | 705,257 | 1,596,239 | 1.6 M to 1.6 M (-0.99 %) |
Mar 16 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Grant | A | 0.00 | 35,000 | 0 | 1,612,253 | 1.6 M to 1.6 M (+2.22 %) |
Mar 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.65 | 100,000 | 364,850 | 503,376 | |
Mar 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 44.07 | 100,000 | 4,407,390 | 1,577,253 | 1.7 M to 1.6 M (-5.96 %) |
Mar 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.65 | 100,000 | 364,850 | 1,677,253 | 1.6 M to 1.7 M (+6.34 %) |
Feb 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.65 | 100,000 | 364,850 | 603,376 | |
Feb 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 51.22 | 32,050 | 1,641,559 | 1,577,253 | 1.6 M to 1.6 M (-1.99 %) |
Feb 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 50.71 | 67,950 | 3,445,513 | 1,609,303 | 1.7 M to 1.6 M (-4.05 %) |
Feb 12 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.65 | 100,000 | 364,850 | 1,677,253 | 1.6 M to 1.7 M (+6.34 %) |
Jan 23 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | A | 47.20 | 300,000 | 14,160,000 | 300,000 | |
Jan 15 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.65 | 100,000 | 364,850 | 703,376 | |
Jan 15 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 49.05 | 100,000 | 4,905,150 | 1,577,253 | 1.7 M to 1.6 M (-5.96 %) |
Jan 15 2009 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.65 | 100,000 | 364,850 | 1,677,253 | 1.6 M to 1.7 M (+6.34 %) |
Dec 23 2008 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.70 | 27,024 | 99,970 | 0 | |
Dec 23 2008 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.70 | 27,024 | 99,970 | 1,577,253 | 1.6 M to 1.6 M (+1.74 %) |
Aug 14 2008 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 3.65 | 70,000 | 255,395 | 803,376 | |
Aug 14 2008 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 56.82 | 70,000 | 3,977,729 | 1,550,229 | 1.6 M to 1.6 M (-4.32 %) |
Aug 14 2008 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 3.65 | 70,000 | 255,395 | 1,620,229 | 1.6 M to 1.6 M (+4.52 %) |